Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Subhash Chand

3PUBLICATIONS
3CO-AUTHORS
Molecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|May 18, 2026
Current Landscape of Anti-HER2 Targeted Therapy in Breast Cancer: Challenges and Future Perspectives.

|Jan 25, 2025
A Cost-Effective and Robust Cell-Based Bioassay Method for Evaluating the Bioactivity of Trastuzumab-like Antibodies.

Pooja Bharali, Subhash Chand, Harish Chander

|Nov 16, 2020
Comparative analytical profiling of bevacizumab biosimilars marketed in India: a national control laboratory study.

Anu Prakash, Nripendra N Mishra, Utpreksha Vaish

Pageof 1

Frequent Collaborators

1 joint publications

Pooja Bharali

1 joint publications

Vikrant Mehta

1 joint publications

Harish Chander

Frequent Collaborators

1 joint publications

Pooja Bharali

1 joint publications

Vikrant Mehta

1 joint publications

Harish Chander